Comparison of pulse methotrexate and pulse dactinomycin in the treatment of low-risk gestational trophoblastic neoplasia

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 45, Issue 2, 2005, Pages 161-164

  Gilani, Mitra Modares ^a   Yarandi, Fariba ^a,c   Eftekhar, Zahra ^a   Hanjani, Parviz ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ABINGTON MEMORIAL HOSPITAL   (United States)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

hCG; Dactinomycingestational trophoblastic neoplasia; Methotrexate

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; DACTINOMYCIN; METHOTREXATE;

ADOLESCENT; ADULT; ARTICLE; BLOOD TOXICITY; CANCER RISK; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG PULSE THERAPY; DRUG RESPONSE; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; HUMAN TISSUE; LIVER TOXICITY; NAUSEA; NEPHROTOXICITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; STOMATITIS; TROPHOBLASTIC TUMOR; VOMITING;

ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS; DACTINOMYCIN; FEMALE; GESTATIONAL TROPHOBLASTIC NEOPLASMS; HUMANS; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAMUSCULAR; METHOTREXATE; PREGNANCY; PULSE THERAPY, DRUG; TREATMENT OUTCOME;

EID: 17244374396     PISSN: 00048666     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1479-828X.2005.00366.x     Document Type: Article

References (11)

1. FIGO Oncology Committee. FIGO. Staging for gestational trophoblastic neoplasia 2000. J. Gynaecol. Obstet 2002; 77: 285-287.
2. Hertz R, Li MC, Spencer DB. Effect of methotrexate therapy upon choriocarcinoma and chorioadenoma. Proc. Soc. Exp. Biol. Med. 1956; 93: 361-366.
3. Ross GT, Stolbach LL, Hertz R. Actinomycin D in the treatment of methotrexate-resistant trophoblastic disease in women. Cancer Res. 1962; 22: 1015-1017.
4. Berkowitz RS, Goldstein DP. Methotrexate with citrovorum factor rescue for non-metastatic gestational Trophoblastic neoplasms. Obstet Gynecol. 1979; 54: 725-728.
5. Hoffman MS, Fiorica JV, Gleeson NC, Roberts WS, Cavanagh D. A single institution experience with weekly intramuscular methotrexate for non-metastatic gestational Trophoblastic disease. Gynecol. Oncol. 1996; 60: 292-294.
6. Homesley HD, Blessing JA, Schlaerth J, Rettenmaier M, Major FJ. Rapid escalation of weekly intramuscular Methotrexate for non-metastatic gestational Trophoblastic disease: A Gynecologic Oncology Group study. Gynecol. Oncol. 1990; 39: 305-308.
7. Petrilli ES, Morrow CP. Actinomycin D toxicity in the treatment of trophoblastic disease: a comparison of the five-day course to single-dose administration. Gynecol. Oncol. 1980; 9: 18-22.
8. Petrilli ES, Twiggs LB, Blessing JA, Teng NH, Curry S. Single dose actinomycin-D treatment for non-metastatic gestational trophoblastic disease, a prospective phase II trial of the Gynecologic Oncology Group. Cancer 1987; 60: 2173-2176.
9. Homesley HD. Single agent therapy for non-metastatic and low risk GTD. J. Reprod Med. 1998; 43: 69-73.
10. Schlaerth JB, Morrow CP, Nalick RH, Gaddis O Jr. Single-dose actinomycin D in the treatment of postmolar trophoblastic disease. Gynecol. Oncol. 1984; 19: 53-56.
11. Kwon JS, Elit L, Mazurka J, Moens F, Schmuck ML. Weekly intravenous methotrexate with folinic acid for nonmetastatic gestational trophoblastic neoplasia. Gynecol. Oncol. 2001; 82: 367-370.